SEC Form 4 · accession 0001645627-17-000075
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Jun 2, 2017
Accepted (ET)
Jun 6, 2017 · 12:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 2, 2017 | P | 1,000 | $0.065 | A | 21,079,349 | D | |
| Common Stock | Jun 2, 2017 | P | 1,000 | $0.0649 | A | 21,080,349 | D | |
| Common Stock | Jun 2, 2017 | P | 1,000 | $0.0638 | A | 21,081,349 | D | |
| Common Stock | Jun 2, 2017 | P | 1,000 | $0.0647 | A | 21,082,349 | D | |
| Common Stock | Jun 2, 2017 | P | 1,000 | $0.064 | A | 21,083,349 | D | |
| Common Stock | Jun 2, 2017 | P | 1,000 | $0.064 | A | 21,084,349 | D | |
| Common Stock | Jun 2, 2017 | P | 1,000 | $0.0649 | A | 21,085,349 | D | |
| Common Stock | Jun 2, 2017 | P | 1,000 | $0.0649 | A | 21,086,349 | D | |
| Common Stock | Jun 2, 2017 | P | 1,000 | $0.0645 | A | 21,087,349 | D | |
| Common Stock | Jun 2, 2017 | P | 1,000 | $0.065 | A | 21,088,349 | D | |
| Common Stock | Jun 2, 2017 | P | 1,000 | $0.065 | A | 21,089,349 | D | |
| Common Stock | Jun 2, 2017 | P | 1,000 | $0.064 | A | 21,090,349 | D | |
| Common Stock | Jun 2, 2017 | P | 1,000 | $0.064 | A | 21,091,349 | D | |
| Common Stock | Jun 2, 2017 | P | 1,000 | $0.061 | A | 21,092,349 | D | |
| Common Stock | Jun 2, 2017 | P | 1,000 | $0.061 | A | 21,095,349 | D |
Table II — derivative securities
No Table II lines on this filing.